162 related articles for article (PubMed ID: 38011683)
1. Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis.
Duan F; Liu C; Chang C; Song S; Zhai H; Cheng J; Yang S
Am J Drug Alcohol Abuse; 2024 Mar; 50(2):191-206. PubMed ID: 38011683
[No Abstract] [Full Text] [Related]
2. Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis.
Singh V; Keisham A; Bhalla A; Sharma N; Agarwal R; Sharma R; Singh A
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1650-1656.e2. PubMed ID: 29391265
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.
Singh S; Murad MH; Chandar AK; Bongiorno CM; Singal AK; Atkinson SR; Thursz MR; Loomba R; Shah VH
Gastroenterology; 2015 Oct; 149(4):958-70.e12. PubMed ID: 26091937
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.
Louvet A; Thursz MR; Kim DJ; Labreuche J; Atkinson SR; Sidhu SS; O'Grady JG; Akriviadis E; Sinakos E; Carithers RL; Ramond MJ; Maddrey WC; Morgan TR; Duhamel A; Mathurin P
Gastroenterology; 2018 Aug; 155(2):458-468.e8. PubMed ID: 29738698
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis.
Parker R; Armstrong MJ; Corbett C; Rowe IA; Houlihan DD
Aliment Pharmacol Ther; 2013 May; 37(9):845-54. PubMed ID: 23489011
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Granulocyte Colony-stimulating Factor in the Management of Steroid-Nonresponsive Severe Alcoholic Hepatitis: A Double-Blind Randomized Controlled Trial.
Shasthry SM; Sharma MK; Shasthry V; Pande A; Sarin SK
Hepatology; 2019 Sep; 70(3):802-811. PubMed ID: 30664267
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.
Akriviadis E; Botla R; Briggs W; Han S; Reynolds T; Shakil O
Gastroenterology; 2000 Dec; 119(6):1637-48. PubMed ID: 11113085
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy: A Systematic Review and Meta-Analysis.
Lee YS; Kim HJ; Kim JH; Yoo YJ; Kim TS; Kang SH; Suh SJ; Joo MK; Jung YK; Lee BJ; Seo YS; Yim HJ; Yeon JE; Kim JS; Park JJ; Um SH; Bak YT; Byun KS
J Clin Gastroenterol; 2017 Apr; 51(4):364-377. PubMed ID: 27636406
[TBL] [Abstract][Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial.
Thursz M; Forrest E; Roderick P; Day C; Austin A; O'Grady J; Ryder S; Allison M; Gleeson D; McCune A; Patch D; Wright M; Masson S; Richardson P; Vale L; Mellor J; Stanton L; Bowers M; Ratcliffe I; Downs N; Kirkman S; Homer T; Ternent L
Health Technol Assess; 2015 Dec; 19(102):1-104. PubMed ID: 26691209
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.
Colli A; Fraquelli M; Prati D; Casazza G
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013532. PubMed ID: 37278488
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial).
Sidhu SS; Goyal O; Singla P; Gupta D; Sood A; Chhina RS; Soni RK
Dig Dis Sci; 2012 Jun; 57(6):1664-71. PubMed ID: 22388710
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline for alcoholic hepatitis.
Whitfield K; Rambaldi A; Wetterslev J; Gluud C
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007339. PubMed ID: 19821406
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials.
Njei B; Do A; McCarty TR; Fortune BE
J Clin Gastroenterol; 2016; 50(10):871-881. PubMed ID: 27404293
[TBL] [Abstract][Full Text] [Related]
15. [Is there a role for pentoxifylline in the treatment of alcoholic hepatitis?].
Caballeria J
Gastroenterol Hepatol; 2016 Oct; 39(8):560-5. PubMed ID: 26589540
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials.
Marot A; Singal AK; Moreno C; Deltenre P
JHEP Rep; 2020 Oct; 2(5):100139. PubMed ID: 32775975
[TBL] [Abstract][Full Text] [Related]
17. G-CSF and GM-CSF for treating or preventing neonatal infections.
Carr R; Modi N; Doré C
Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
[TBL] [Abstract][Full Text] [Related]
18. New paradigms in management of alcoholic hepatitis: a review.
Sidhu SS; Goyal O; Kishore H; Sidhu S
Hepatol Int; 2017 May; 11(3):255-267. PubMed ID: 28247264
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial.
Sidhu SS; Goyal O; Singla M; Bhatia KL; Chhina RS; Sood A
J Assoc Physicians India; 2012 May; 60():20-2. PubMed ID: 23029716
[TBL] [Abstract][Full Text] [Related]
20. Determinants of long-term outcome in severe alcoholic hepatitis.
Potts JR; Goubet S; Heneghan MA; Verma S
Aliment Pharmacol Ther; 2013 Sep; 38(6):584-95. PubMed ID: 23879720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
